Serum- and glucocorticoid-inducible kinase 3 (SGK3) is a serine/threonine kinase that plays a crucial role in the regulation of various cellular processes, including ion transport, cell survival, proliferation, and apoptosis. As a member of the AGC kinase family, SGK3 is structurally and functionally related to the Akt kinases and shares a similar substrate specificity. It is distinguished by its unique activation mechanism via the phosphoinositide 3-kinase (PI3K) pathway, particularly through the production of phosphatidylinositol 3-phosphate (PI3P), which is essential for its localization to early endosomes. SGK3 is implicated in the regulation of the sodium channel ENaC, as well as in the modulation of other transporters and channels, contributing to the control of cellular ion homeostasis. Furthermore, SGK3 has been identified as a key player in signaling pathways that promote cell growth and survival, making it a significant enzyme in understanding the molecular mechanisms underlying various physiological and pathological states, including its contribution to cancer cell survival and proliferation.
The inhibition of SGK3 involves specific mechanisms that can directly or indirectly affect its kinase activity, expression levels, or cellular localization. Direct inhibition primarily focuses on targeting the catalytic activity of SGK3, which could be achieved by small molecules that compete with ATP binding or substrates at the active site of the kinase. Such inhibitors can effectively block the phosphorylation of SGK3 substrates, thereby preventing the downstream signaling events essential for its cellular functions. Indirect mechanisms of SGK3 inhibition may include modulating the PI3K pathway or affecting the synthesis of PI3P, which is crucial for SGK3 activation and localization to endosomes. Additionally, alterations in the expression levels of SGK3 through genetic modifications, such as knockdown or knockout techniques, represent another approach to study the functional consequences of SGK3 inhibition. Understanding these inhibitory mechanisms is critical for elucidating the complex regulatory networks that control cell physiology and offers insights into potential strategies for targeting SGK3.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BI-D1870 | 501437-28-1 | sc-397022 sc-397022A | 1 mg 5 mg | $92.00 $260.00 | 12 | |
BI-D1870 is a potent and selective inhibitor of SGK3, acting by targeting the ATP-binding site of the kinase. Through this mechanism, BI-D1870 disrupts the phosphorylation of SGK3 substrates and influences downstream signaling pathways, especially those related to cell survival and proliferation. The chemical’s specificity for SGK3 makes it an invaluable tool for researchers investigating SGK3-related cellular functions. | ||||||